Home › NDC Lookup › RxCUI directory › RxCUI 208186

Silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] — RxCUI 208186

RxNorm drug concept · Semantic branded drug
RxCUI 208186 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI208186
Official nameSilver sulfadiazine 10 MG/ML Topical Cream [Silvadene]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asSilvadene 1 % Topical Cream; Silvadene 10 MG/ML Topical Cream
FDA products mapped2
Package NDCs mapped8
Reported Medicaid activity (SDUD)666 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Silver Sulfadiazine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Silver sulfadiazine cream is applied to second- and third-degree burn wounds to help prevent and treat serious infection. It's not a standalone treatment — your care team uses it a...
  • After the wound is cleaned and any dead tissue is removed, the cream is spread in a thin layer — about 1/16 of an inch — directly over the burn area. It's applied once or twice a d...
  • A temporary dip in white blood cells, especially a type called neutrophils, is actually one of the more commonly reported effects — it happens in roughly 1 in 5 patients. The good...
  • My white blood cell count went down — should I be worried?
📖 Read our full Silver Sulfadiazine guide →

🕸️ Concept Web — How Silver sulfadiazine 10 MG/ML Topical Cream [Silv... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Silver sulfadiazine 10 MG/ML Topical Cream [Silvadene] RxCUI 208186

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Silver sulfadiazine 9793
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Silvadene 224926
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Silver sulfadiazine Topical Cream 377813
    • Silver sulfadiazine Topical Product 1158745
    • Silver sulfadiazine Topical Cream [Silvadene] 362123
    • Silvadene Topical Product 1182619
    • Topical Cream 316982
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Silver sulfadiazine 10 MG/ML [Silvadene] SBDC · 568907
  • Silver sulfadiazine Topical Cream [Silvadene] SBDF · 362123
  • Silvadene Topical Product SBDG · 1182619
  • Silvadene BN · 224926

📦 FDA Products & Package NDCs

2 products · 8 package NDCs
8 package NDCs map to RxCUI 208186 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50090-0230-00 1 TUBE in 1 CARTON (50090-0230-0) / 20 g in 1 TUBE SILVADENE A-S Medication Solutions 2016-06-29
61570-0131-20 1 TUBE in 1 CARTON (61570-131-20) / 20 g in 1 TUBE SILVADENE Pfizer Laboratories Div Pfizer Inc 1973-11-26
61570-0131-25 1 TUBE in 1 CARTON (61570-131-25) / 25 g in 1 TUBE SILVADENE Pfizer Laboratories Div Pfizer Inc 2015-05-26
61570-0131-40 400 g in 1 JAR (61570-131-40) SILVADENE Pfizer Laboratories Div Pfizer Inc 1973-11-26
61570-0131-50 50 g in 1 JAR (61570-131-50) SILVADENE Pfizer Laboratories Div Pfizer Inc 1973-11-26
61570-0131-55 1 TUBE in 1 CARTON (61570-131-55) / 50 g in 1 TUBE SILVADENE Pfizer Laboratories Div Pfizer Inc 2015-05-26
61570-0131-85 1 TUBE in 1 CARTON (61570-131-85) / 85 g in 1 TUBE SILVADENE Pfizer Laboratories Div Pfizer Inc 1973-11-26
61570-0131-98 1000 g in 1 JAR (61570-131-98) SILVADENE Pfizer Laboratories Div Pfizer Inc 1973-11-26
Observed labelers: Pfizer Laboratories Div Pfizer Inc (7) · A-S Medication Solutions (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$0.2590
Range $0.1247–$0.4341 · middle 50% $0.2447–$0.2847 · 6 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.